Submitted by Anonymous (not verified) on 22 September 2026 - 15:36
Human medicines European public assessment report (EPAR): Xbonzy, denosumab, Date of authorisation: 17/11/2025, Revision: 3, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Xbonzy, denosumab, Date of authorisation: 17/11/2025, Revision: 3, Status: Authorised